BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1296 related articles for article (PubMed ID: 28103885)

  • 21. Identification of novel long non-coding RNA biomarkers for prognosis prediction of papillary thyroid cancer.
    Li Q; Li H; Zhang L; Zhang C; Yan W; Wang C
    Oncotarget; 2017 Jul; 8(28):46136-46144. PubMed ID: 28545026
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bioinformatic validation identifies candidate key genes in diffuse large-B cell lymphoma.
    Huang Q; Liu F; Shen J
    Per Med; 2019 Jul; 16(4):313-323. PubMed ID: 31331250
    [No Abstract]   [Full Text] [Related]  

  • 23. Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathways.
    Lenz G; Wright GW; Emre NC; Kohlhammer H; Dave SS; Davis RE; Carty S; Lam LT; Shaffer AL; Xiao W; Powell J; Rosenwald A; Ott G; Muller-Hermelink HK; Gascoyne RD; Connors JM; Campo E; Jaffe ES; Delabie J; Smeland EB; Rimsza LM; Fisher RI; Weisenburger DD; Chan WC; Staudt LM
    Proc Natl Acad Sci U S A; 2008 Sep; 105(36):13520-5. PubMed ID: 18765795
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A 9 series microRNA signature differentiates between germinal centre and activated B-cell-like diffuse large B-cell lymphoma cell lines.
    Culpin RE; Proctor SJ; Angus B; Crosier S; Anderson JJ; Mainou-Fowler T
    Int J Oncol; 2010 Aug; 37(2):367-76. PubMed ID: 20596664
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The isotype of the BCR as a surrogate for the GCB and ABC molecular subtypes in diffuse large B-cell lymphoma.
    Ruminy P; Etancelin P; Couronné L; Parmentier F; Rainville V; Mareschal S; Bohers E; Burgot C; Cornic M; Bertrand P; Lenormand B; Picquenot JM; Jardin F; Tilly H; Bastard C
    Leukemia; 2011 Apr; 25(4):681-8. PubMed ID: 21233831
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of protein-based cell-of-origin classification to the Lymph2Cx RNA assay in a cohort of diffuse large B-cell lymphomas in Malaysia.
    Phang KC; Akhter A; Tizen NMS; Rahman FA; Zahratul Azma R; Elyamany G; Shabani-Rad MT; Masir N; Mansoor A
    J Clin Pathol; 2018 Mar; 71(3):215-220. PubMed ID: 28775174
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Integrative analysis of protein-coding and non-coding RNAs identifies clinically relevant subtypes of clear cell renal cell carcinoma.
    Li Z; Chen Y; Hu S; Zhang J; Wu J; Ren W; Shao N; Ying X
    Oncotarget; 2016 Dec; 7(50):82671-82685. PubMed ID: 27705920
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transcriptome profiling reveals an integrated mRNA-lncRNA signature with predictive value for long-term survival in diffuse large B-cell lymphoma.
    Gao Q; Li Z; Meng L; Ma J; Xi Y; Wang T
    Aging (Albany NY); 2020 Nov; 12(22):23275-23295. PubMed ID: 33221755
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Subtype-specific addiction of the activated B-cell subset of diffuse large B-cell lymphoma to FOXP1.
    Dekker JD; Park D; Shaffer AL; Kohlhammer H; Deng W; Lee BK; Ippolito GC; Georgiou G; Iyer VR; Staudt LM; Tucker HO
    Proc Natl Acad Sci U S A; 2016 Feb; 113(5):E577-86. PubMed ID: 26787899
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Constitutive nuclear factor kappaB activity is required for survival of activated B cell-like diffuse large B cell lymphoma cells.
    Davis RE; Brown KD; Siebenlist U; Staudt LM
    J Exp Med; 2001 Dec; 194(12):1861-74. PubMed ID: 11748286
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunohistochemical classification of de novo, transformed, and relapsed diffuse large B-cell lymphoma into germinal center B-cell and nongerminal center B-cell subtypes correlates with gene expression profile and patient survival.
    Haarer CF; Roberts RA; Frutiger YM; Grogan TM; Rimsza LM
    Arch Pathol Lab Med; 2006 Dec; 130(12):1819-24. PubMed ID: 17149956
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of genome profiles for identification of distinct subgroups of diffuse large B-cell lymphoma.
    Tagawa H; Suguro M; Tsuzuki S; Matsuo K; Karnan S; Ohshima K; Okamoto M; Morishima Y; Nakamura S; Seto M
    Blood; 2005 Sep; 106(5):1770-7. PubMed ID: 15886317
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Different predictive values of interim
    Kim J; Lee JO; Paik JH; Lee WW; Kim SE; Song YS
    Ann Nucl Med; 2017 Jan; 31(1):1-11. PubMed ID: 27627889
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Integrative analysis of hub genes and key pathway in two subtypes of diffuse large B-cell lymphoma by bioinformatics and basic experiments.
    Li Q; Meng Y; Hu L; Charwudzi A; Zhu W; Zhai Z
    J Clin Lab Anal; 2021 Nov; 35(11):e23978. PubMed ID: 34545634
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A gene expression-based method to diagnose clinically distinct subgroups of diffuse large B cell lymphoma.
    Wright G; Tan B; Rosenwald A; Hurt EH; Wiestner A; Staudt LM
    Proc Natl Acad Sci U S A; 2003 Aug; 100(17):9991-6. PubMed ID: 12900505
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A potential signature of eight long non-coding RNAs predicts survival in patients with non-small cell lung cancer.
    Zhou M; Guo M; He D; Wang X; Cui Y; Yang H; Hao D; Sun J
    J Transl Med; 2015 Jul; 13():231. PubMed ID: 26183581
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long noncoding RNA HULC predicts poor clinical outcome and represents pro-oncogenic activity in diffuse large B-cell lymphoma.
    Peng W; Wu J; Feng J
    Biomed Pharmacother; 2016 Apr; 79():188-93. PubMed ID: 27044827
    [TBL] [Abstract][Full Text] [Related]  

  • 38. FOXP1 suppresses immune response signatures and MHC class II expression in activated B-cell-like diffuse large B-cell lymphomas.
    Brown PJ; Wong KK; Felce SL; Lyne L; Spearman H; Soilleux EJ; Pedersen LM; Møller MB; Green TM; Gascoyne DM; Banham AH
    Leukemia; 2016 Mar; 30(3):605-16. PubMed ID: 26500140
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A B-cell-associated gene signature classification of diffuse large B-cell lymphoma by NanoString technology.
    Michaelsen TY; Richter J; Brøndum RF; Klapper W; Johnsen HE; Albertsen M; Dybkær K; Bøgsted M
    Blood Adv; 2018 Jul; 2(13):1542-1546. PubMed ID: 29967255
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Elevated RNA expression of long non‑coding HOTAIR promotes cell proliferation and predicts a poor prognosis in patients with diffuse large B cell lymphoma.
    Yan Y; Han J; Li Z; Yang H; Sui Y; Wang M
    Mol Med Rep; 2016 Jun; 13(6):5125-31. PubMed ID: 27122348
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 65.